Aliana Rao, Samuel L Ricci, Theodore C Hannah, Erin K M Graves, Anand Kaul, Eric T Quach, Rami O Almefty, Kadir Erkmen
{"title":"近端Onyx栓塞脑膜中动脉(POEM)技术治疗非急性硬膜下血肿:一项123例使用Scepter双腔球囊微导管的单中心研究。","authors":"Aliana Rao, Samuel L Ricci, Theodore C Hannah, Erin K M Graves, Anand Kaul, Eric T Quach, Rami O Almefty, Kadir Erkmen","doi":"10.1136/jnis-2025-023999","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Non-acute subdural hematomas (NASDHs) often recur or persist, particularly among older patients with comorbidities. Middle meningeal artery embolization (MMAe) has emerged as a promising primary treatment alternative. Dual-lumen balloon microcatheters significantly reduce the risk of reflux, which is a limitation of single-lumen microcatheters. We evaluated the safety and efficacy of the proximal Onyx embolization of the MMA (POEM) technique using the Scepter Mini and Scepter XC balloon microcatheters.</p><p><strong>Methods: </strong>We conducted a single-center retrospective review of patients with NASDH undergoing Onyx MMAe with the Scepter Mini or Scepter XC microcatheter between July 2020 and January 2025. Demographics, imaging parameters (hematoma thickness, midline shift), procedural details, and clinical and radiographic outcomes were recorded.</p><p><strong>Results: </strong>123 patients underwent Scepter balloon-assisted MMAe. Their mean age was 72 years and 67.5% were male. At 6 months, 77.2% achieved ≥50% reduction in hematoma thickness. There were no significant differences in baseline demographics, hematoma characteristics, or surgical intervention rates between patients achieving ≥50% reduction and those with <50%. Five patients (4.1%) experienced recurrence, with average time to recurrence of 76 days. Only three patients (2.4%) required surgical rescue. Safety outcomes included 6.5% all-cause mortality at 180 days, with 1.6% directly related to NASDH. Stroke occurred in 1.6% at 30 days and 4.1% at 180 days.</p><p><strong>Conclusion: </strong>By minimizing the risk of reflux, balloon-assisted MMAe allows for safe embolization from a more proximal location. The POEM technique shows that proximal embolization with dual-lumen balloon microcatheters treats NASDH effectively, achieving substantial hematoma resolution with low recurrence. Prospective studies comparing POEM with other techniques are warranted to confirm its comparative efficacy.</p>","PeriodicalId":16411,"journal":{"name":"Journal of NeuroInterventional Surgery","volume":" ","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Proximal Onyx embolization of the middle meningeal artery (POEM) technique for non-acute subdural hematomas: a single-center study of 123 patients using the Scepter dual-lumen balloon microcatheter.\",\"authors\":\"Aliana Rao, Samuel L Ricci, Theodore C Hannah, Erin K M Graves, Anand Kaul, Eric T Quach, Rami O Almefty, Kadir Erkmen\",\"doi\":\"10.1136/jnis-2025-023999\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Non-acute subdural hematomas (NASDHs) often recur or persist, particularly among older patients with comorbidities. Middle meningeal artery embolization (MMAe) has emerged as a promising primary treatment alternative. Dual-lumen balloon microcatheters significantly reduce the risk of reflux, which is a limitation of single-lumen microcatheters. We evaluated the safety and efficacy of the proximal Onyx embolization of the MMA (POEM) technique using the Scepter Mini and Scepter XC balloon microcatheters.</p><p><strong>Methods: </strong>We conducted a single-center retrospective review of patients with NASDH undergoing Onyx MMAe with the Scepter Mini or Scepter XC microcatheter between July 2020 and January 2025. Demographics, imaging parameters (hematoma thickness, midline shift), procedural details, and clinical and radiographic outcomes were recorded.</p><p><strong>Results: </strong>123 patients underwent Scepter balloon-assisted MMAe. Their mean age was 72 years and 67.5% were male. At 6 months, 77.2% achieved ≥50% reduction in hematoma thickness. There were no significant differences in baseline demographics, hematoma characteristics, or surgical intervention rates between patients achieving ≥50% reduction and those with <50%. Five patients (4.1%) experienced recurrence, with average time to recurrence of 76 days. Only three patients (2.4%) required surgical rescue. Safety outcomes included 6.5% all-cause mortality at 180 days, with 1.6% directly related to NASDH. Stroke occurred in 1.6% at 30 days and 4.1% at 180 days.</p><p><strong>Conclusion: </strong>By minimizing the risk of reflux, balloon-assisted MMAe allows for safe embolization from a more proximal location. The POEM technique shows that proximal embolization with dual-lumen balloon microcatheters treats NASDH effectively, achieving substantial hematoma resolution with low recurrence. Prospective studies comparing POEM with other techniques are warranted to confirm its comparative efficacy.</p>\",\"PeriodicalId\":16411,\"journal\":{\"name\":\"Journal of NeuroInterventional Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of NeuroInterventional Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/jnis-2025-023999\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NEUROIMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of NeuroInterventional Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/jnis-2025-023999","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROIMAGING","Score":null,"Total":0}
Proximal Onyx embolization of the middle meningeal artery (POEM) technique for non-acute subdural hematomas: a single-center study of 123 patients using the Scepter dual-lumen balloon microcatheter.
Objective: Non-acute subdural hematomas (NASDHs) often recur or persist, particularly among older patients with comorbidities. Middle meningeal artery embolization (MMAe) has emerged as a promising primary treatment alternative. Dual-lumen balloon microcatheters significantly reduce the risk of reflux, which is a limitation of single-lumen microcatheters. We evaluated the safety and efficacy of the proximal Onyx embolization of the MMA (POEM) technique using the Scepter Mini and Scepter XC balloon microcatheters.
Methods: We conducted a single-center retrospective review of patients with NASDH undergoing Onyx MMAe with the Scepter Mini or Scepter XC microcatheter between July 2020 and January 2025. Demographics, imaging parameters (hematoma thickness, midline shift), procedural details, and clinical and radiographic outcomes were recorded.
Results: 123 patients underwent Scepter balloon-assisted MMAe. Their mean age was 72 years and 67.5% were male. At 6 months, 77.2% achieved ≥50% reduction in hematoma thickness. There were no significant differences in baseline demographics, hematoma characteristics, or surgical intervention rates between patients achieving ≥50% reduction and those with <50%. Five patients (4.1%) experienced recurrence, with average time to recurrence of 76 days. Only three patients (2.4%) required surgical rescue. Safety outcomes included 6.5% all-cause mortality at 180 days, with 1.6% directly related to NASDH. Stroke occurred in 1.6% at 30 days and 4.1% at 180 days.
Conclusion: By minimizing the risk of reflux, balloon-assisted MMAe allows for safe embolization from a more proximal location. The POEM technique shows that proximal embolization with dual-lumen balloon microcatheters treats NASDH effectively, achieving substantial hematoma resolution with low recurrence. Prospective studies comparing POEM with other techniques are warranted to confirm its comparative efficacy.
期刊介绍:
The Journal of NeuroInterventional Surgery (JNIS) is a leading peer review journal for scientific research and literature pertaining to the field of neurointerventional surgery. The journal launch follows growing professional interest in neurointerventional techniques for the treatment of a range of neurological and vascular problems including stroke, aneurysms, brain tumors, and spinal compression.The journal is owned by SNIS and is also the official journal of the Interventional Chapter of the Australian and New Zealand Society of Neuroradiology (ANZSNR), the Canadian Interventional Neuro Group, the Hong Kong Neurological Society (HKNS) and the Neuroradiological Society of Taiwan.